Carregant...
Fibrostenotic strictures in Crohn’s disease
The use of biologic agents including anti-tumor necrosis factor monoclonal antibodies followed by anti-integrins and anti-interleukins has drastically changed the treatment paradigm of Crohn’s disease (CD) by improving clinical symptoms and mucosal healing. However, up to 70% of CD patients still ev...
Guardat en:
| Publicat a: | Intest Res |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Korean Association for the Study of Intestinal Diseases
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7609387/ https://ncbi.nlm.nih.gov/pubmed/32259917 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5217/ir.2019.09148 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|